Quotient Sciences Conducts Integrated Translational Pharmaceutics® Program in U.S. With Druggability Technologies

DDL 2018 - The Aerosol Society

November 4 - 7, 2018, Washington, DC, U.S.

We will be exhibiting at the annual AAPS PharmSci 360 events in Washington, DC on 04 - 07 November at booth #2009

Following on from last years event in which we premiered our successful rebrand, we will be showcasing our services at the event once again and presenting five posters; details below. 

Monday, November 5, 2018:

  • 11:30am | Forum 12 | Monitor 95: Identification and Optimization of Critical Process Parameters of Roller Compacted Capsules: From Development to Registration Batches
  • 12:30 -1:30pm | Forum 6 | Monitor 41: Rapid development and clinical assessment of new rectal and oral formulations for ulcerative colitis using real-time adaptive GMP manufacturing and supply

Tuesday, November 6, 2018:

  • 1:30  - 2:30pm | Forum 7 | Monitor 52: Development of a modified release tablet containing an API prone to form changes and gelling in aqueous media
  • 3:30 | Forum 6 | Monitor 47: Evaluation of Process Transferability of Poorly Flowing Blend Between the Blenders Manufactured by Different Vendors

Wednesday, November 7, 2018:

  • 12:30 - 1:30pm | Forum 13 | Monitor 101: Development and Approval of a Palatable Glycopyrronium Bromide Liquid Formulation for Pediatrics
  • 4:00 - 4:15pm | Rapid Fire Presentation 
    Title: Using Real-Time Adaptive GMP Manufacturing to Rapidly Develop and Assess New TOP1288 Formulations for Ulcerative Colitis

Speaker: Nikki Whitfield, VP of CDMO Services. 

Please get in touch to book a meeting or find out more. 

Ask us a question